Here is one one on technology for an early T1 detection.
Washington, June 9: A reliable, highly sensitive diagnostic blood test that identifies Type-1 diabetes patients in time for early intervention is around the corner thanks to the development of a new technology.
http://www.dailyindia.com/show/248023.php/Blood-test-to-identify-Type-1-diabetes-on-the-anvil
also
http://money.cnn.com/news/newsfeeds/articles/primenewswire/144273.htm
Other News:
Generex Biotechnology Commences Patient Dosing For Pivotal Phase III Trial Of Generex Oral-lyn For Type 1 Diabetes
Generex Biotechnology Corporation (NasdaqCM:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has commenced dosing of patients in a Phase III clinical trial of the Company's flagship product, Generex Oral-lynO, an oral insulin spray.
http://www.medicalnewstoday.com/articles/110418.php
No comments :
Post a Comment